Observational studies overestimate smoking’s impact on CKD risk

Plus, news about Abili­ta Ther­a­peu­tics, Ori­on, No­var­tis, XGEN Ven­ture, Palleon, Hen­lius, TigaTx, HER­Vo­lu­tion Ther­a­peu­tics and Krys­tal Biotech: Gilead now owns 30% of As­sem­bly Bio­sciences: The

A group of De­mo­c­ra­t­ic and Re­pub­li­can sen­a­tors in­tro­duced a bill on Thurs­day that calls for $275 mil­lion to­ward fed­er­al menopause re­search and aware­ness ef­forts over

Patients starting targeted therapies for rheumatoid arthritis (RA) were more likely to develop serious infections and other adverse events if they were considered frail, insurance